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AMP-activated protein kinase influences cellular metabolism, glucose-regulated gene expression, and insulin secretion of pancreatic beta cells.
Its sustained activation by culture at low glucose concentrations or in the presence of 5-aminoimidazole-4-carboxamide riboside (AICAR) was
shown to trigger apoptosis in beta cells. This study shows that both low glucose- and AICAR-induced apoptosis are associated with increased
formation of mitochondrial superoxide-derived radicals and decreased mitochondrial activity. Mitochondrial dysfunction was reflected by an
increased oxidized state of the mitochondrial flavins (FMN/FAD) but not of NAD(P)H. It was accompanied by suppression of glucose oxidation
and glucose-induced insulin secretion, while palmitate oxidation appeared unaffected. When the cellular accumulation of superoxide-derived
radicals was quenched by the ROS scavengers vitamin E, N-acetylcysteine, or the SOD-mimetic compound MnTBAP, apoptosis was significantly
inhibited. Both low glucose and AICAR also elevated the expression of BH3-domain-only Bcl-2 antagonists, and induced caspase-3 activation,
causing caspase-dependent truncation of Bcl-2. Overexpression of recombinant human Bcl-2 prevented caspase-3 activation, endogenous Bcl-2
processing, and apoptosis, but did not attenuate oxygen radical formation, AMPK activation, or JNK phosphorylation. We conclude that apoptosis
by prolonged AMPK activation in beta cells results from enhanced production of mitochondria-derived oxygen radicals and onset of the intrinsic
mitochondrial apoptosis pathway, followed by caspase activation and Bcl-2 cleavage which may amplify the death signal.
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Metabolic activity is crucial to the survival of pancreatic beta
cells in vitro [1]. Conditions under which AMP-activated
protein kinase (AMPK) is stimulated in beta cells are associated
with a reduced biosynthetic and functional state of the cells.Abbreviations: BSA, bovine serum albumin; AICAR, 5-aminoimidazole-4-
carboxamide riboside; AMPK, AMP-activated protein kinase; DMEM,
Dulbecco's modified Eagle's medium; FCS, fetal calf serum; GSIS, glucose-
stimulated insulin secretion; H2-DCFDA, dihydrodichlorofluorescein diacetate;
DHE, dihydroethidine; MFI, mean absolute fluorescence intensities; MTT,
3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide; NAC, N-acetyl-
cysteine; ROS, reactive oxygen species; RT-PCR, reverse transcriptase-
polymerase chain reaction; MTT, (3-(4,5-dimethylthiazolyl-2)-2,5-diphenylte-
trazolium bromide; SOD, superoxide dismutase.
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doi:10.1016/j.freeradbiomed.2006.09.018This has been demonstrated for culture in low glucose
concentrations or in the presence of the AMPK activators 5-
aminoimidazole-4-carboxamide riboside (AICAR) and metfor-
min, as well as for adenovirus-mediated expression of
constitutively active (CA)-AMPK [2–7]. We and others showed
that when this state is prolonged in vitro, insulin producing
MIN6 cells and primary beta cells die via an apoptosis program
that is dependent on the activation of AMPK [3–5,7] and
involves c-Jun N-terminal kinase [4]. AMPK-mediated apop-
tosis has been reported in other cell types [8–12]. Conversely, it
is recognized that activation of the kinase leads to metabolic
alterations that can prevent ATP depletion in certain cell types
[13–15] resulting in improved survival under stress conditions
and protection from apoptosis [16–20]. Beneficial effects of the
AMPK activator metformin have been reported in human
pancreatic islets exposed to high free fatty acid levels in vitro
[21]. In view of its wide range of cellular effects, AMPK holds
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is unclear how cell dysfunction and apoptosis can result from
AMPK activation. This knowledge could be useful for
minimizing the detrimental effects that are associated with a
persistent kinase stimulation in beta cells [7]. On the other hand,
it may be useful to promote these effects in cancer cells [22].
Sustained AMPK activation in beta cells and MIN6 cells can
be provoked by culture in low glucose or in the presence of the
AMPK stimulator AICAR [23]. These models have been used
to identify mechanisms that contribute to AMPK-mediated beta
cell death [3–5]. We recently found that production of reactive
oxygen species in beta cells is increased when extracellular
glucose is low or when mitochondrial metabolic activity is
decreased [24]. In this study we investigate the putative
involvement of ROS production and mitochondrial dysfunction
in AMPK-mediated apoptosis of beta cells.
Materials and methods
Cell culture
Rat pancreatic beta cells were isolated by flow cytometry
[25] and precultured overnight in suspension or as adherent
cells in Ham's F10 medium (Invitrogen, Life Technologies,
Inc., Paisley, Scotland) containing glucose (10 mM), 1% (wt/
vol) charcoal-treated BSA (Sigma, St. Louis, MO), L-glutamine
(2 mM), IBMX (50 μM), penicillin (0.075 mg/ml), and
streptomycin (0.1 mg/ml), as previously described [26].
Subsequently, beta cells were cultured either in 10 or 3 mM
glucose, or in 10 mM glucose containing AICAR (1-2 mM), for
the indicated time periods. Mouse insulin-producingMIN6 cells
(passages 20-32) were cultured in Dulbecco's modified Eagle's
medium (DMEM) containing 15% (v/v) heat-inactivated fetal
calf serum (FCS), as described [27]. At 60-70% confluency,
MIN6 cells were exposed to 25 mM glucose (control
conditions), 0.6 mM glucose (low glucose conditions), or
2 mM AICAR (in 25 mM glucose), always in DMEM
containing 15% FCS [4]. The general caspase inhibitor z-
VAD-fmk (Bachem, Bubendorf, Switzerland) was added to cell
cultures at a concentration of 50 μM, 1 h before transferring the
cells to apoptogenic culture conditions. The compounds vitamin
E (5-25 μM; Merck, Darmstadt, Germany), NAC (N-acetylcys-
teine; 1 mM; Sigma), and the superoxide dismutase (SOD)
mimetic compound MnTBAP (manganese(III)tetrakis(4-ben-
zoic acid)porphyrin; 10-20 μM, Alexis Biochemicals, Lausen,
Germany) were added to the cultures to decrease intracellular
reactive oxygen species. Pyruvate (5-20 mM; Merck), which
can be metabolized by MIN6 cells, was used for replacing
glucose as metabolic fuel [28].
Insulin measurements
MIN6 cells were cultured for 24 h under the indicated
conditions, washed, and cultured in KRHB medium without
glucose for 1 h, followed by incubation for 2 h in KRHB
medium (comprising 116.4 mM NaCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, 5.4 mM KCl, 1.02 mM NaH2PO4, 0.075 mM BSA,26.2 mM NaHCO3), at different glucose concentrations (0, 5,
10, or 25 mM). At the end of culture, medium was taken for
measurement of insulin release, and cells were collected for
analysis of their insulin content. Secreted insulin and total
cellular insulin were measured by radioimmunoassay, as
previously described [29].
Glucose and palmitate oxidation
MIN6 cells were precultured for 24 h under the indicated
conditions. CO2 formation from glucose and palmitate was
measured in duplicate samples of 105 MIN6 cells and
incubated for 2 h at 37°C in 100 μl of the appropriate medium.
Glucose metabolism was measured in Ham's F10 medium
containing 0.5% BSA, 2 mM L-glutamine, 10 mM Hepes, and
10 mM D-glucose (5 μCi D-[U-14C]glucose). Palmitate
metabolism was measured in KRBH medium, containing
0.2% BSA (fraction V), 2 mM calcium, 10 mM Hepes,
0.5 μCi [U-14C]palmitic acid, and unlabeled palmitate up to a
final concentration of 50 μM. Cells were incubated at 37°C in a
glass siliconized tube trapped in an airtight glass vial. After 2 h,
the metabolism was stopped by injecting 20 μl HCl 1 N, and
250 μl hydroxyhiamine (Packard Bioscience, Groningen, The
Netherlands) was used to capture the produced 14CO2 for 1 h at
room temperature. D-[U-14C]Glucose or [U-14C]palmitic acid
oxidation rates were determined by liquid scintillation counting
of the generated 14CO2.
Measurement of redox state
The metabolic redox state of MIN6 cell populations was
analyzed after 30-min incubation in humidified air (20% O2/5%
CO2) at 37°C. It was determined by flow cytometry measuring
cellular fluorescence of NAD(P)H (argon laser 351–363/400–
470 nm) and mitochondrial riboflavin (FAD and FMN, argon
laser 488/530 nm) using a dual-laser FACStar Plus system (BD
Biosciences) [30]. Mean absolute fluorescence intensities (MFI)
were measured for 10,000 propidium iodide (PI, 5 μg/ml)-
negative cells. Cellular NAD(P)H and flavin fluorescence was
measured in cells cultured in 25 mM glucose or 0.6 mM
glucose, either with or without AICAR. Brief exposure (5 min)
to antimycin A (Sigma-Aldrich) was used as a positive control.
Data were expressed relative to the MFI of control MIN6 cell
populations cultured in 25 mM glucose.
Measurement of H2O2 and superoxide
The production of reactive oxygen species (ROS) in MIN6
cells was measured as recently described for beta cells [24].
Briefly, MIN6 cells cultured in 24-well plates (3-5×105 cells per
well) were incubated for 1 h with the cell-permeable fluorescent
ROS-probe dihydrodichlorofluorescein diacetate (H2-DCFDA;
10 μM), or for 20minwith the superoxide probe dihydroethidine
(DHE; 2.5 μM; Molecular Probes, Invitrogen), after which the
cells were washed in DMEM and collected. Cellular fluores-
cence derived from oxidized probes was measured by FACS
[24]. FACS data were presented as the mean fluorescence
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of cells cultured under control conditions (25 mM glucose).
Mitochondrial activity
Reduction of MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphe-
nyltetrazolium bromide) to insoluble formazan by mitochon-
drial dehydrogenases can be used to measure mitochondrial
nutrient metabolism in many cell types, and correlates well
with glucose oxidation in pancreatic β-cells [31,32]. The MTT
reduction assay was used to examine the mitochondrial
activity and metabolic effects of glucose limitation and
AICAR in MIN6 cells. Briefly, cells were seeded at 25,000
cells/well into 96-well plates and grown for 3 days. The
amount of 10 μl of MTT (5 mg/ml in PBS) was added, and the
incubation was allowed to proceed for an additional 2 h.
Insoluble precipitated formazan produced was dissolved in
100 μl dimethyl sulfoxide following 10 min centrifugation of
the microtiter plate at 3000 rpm/4°C and removal of the
supernatant. Absorbance was measured on a Wallac Victor2
microplate reader at 490 nm. Data are expressed as absorbance
(A490) values and normalized to the parallel control response
of cells incubated for the identical time period in 25 mM
glucose.
Plasmids
Empty vector pEF1 (pEF1/V5-HisA) and the recombinant
plasmids pNLS-EGFP, pCAGGS-p35, pEF1-crmA (pEF1/V5-
HisA-crmA), and pEF1-hBcl-2 (pEF1/V5-HisA-hBcl-2)
expressing respectively the GFP, baculovirus p35, cowpox
crmA, and human Bcl-2 gene were a gift from Dr. P.
Vandenabeele (Ghent University, Belgium) or obtained from
the Belgian coordinated collections of microorganisms
(BCCM): laboratory of molecular biology-plasmid collection
(LMBP). They were amplified in Escherichia coli (Strain:
DHSK-F) and isolated using NucleoBond columns (Machery-
Nagel, Gutenberg, Germany).
Transient transfections
MIN6 cells were cultured to 60–70% confluence in 6-well
plates and were transfected with 1 μg of plasmid DNA using
Lipofectamine Plus reagents according to the manufacturer's
instructions (Invitrogen, Paisley, Scotland). To each well, 0.5 μg
of a plasmid expressing nuclearly targeted green fluorescent
protein (pNLS-EGFP) together with 0.5 μg of plasmid
expressing crmA, p35, or human Bcl-2 cDNA were applied.
After lipid-mediated DNA transfection for 3 h, cells were
cultured for 24 h in normal medium, and then cultured under
apoptogenic or control conditions.
Generation of stable MIN6 cell transfectants
MIN6 cells were transfected either with empty vector pEF1,
or with plasmid pEF1-hBcl-2, as described above. The cells
were reseeded 24 h later as single cells, and cultured for 5 weeksin the presence of 400 μg/ml geneticin G418 (Invitrogen). NeoR
(neomycin resistant) cell colonies were picked up from the
culture substratum under an inverted microscope using a sterile
siliconized Pasteur pipette and transferred to selective medium
(200 μg/ml G418) for expansion. The NeoR cells were
examined for expression of human Bcl-2 protein by Western
blotting, before they were used in further experiments. The
hBcl-2 protein content in each NeoR line remained stable for at
least 2 months.
Assay of apoptosis and caspase-3 activity
Living, apoptotic and necrotic MIN6 cells were identified by
fluorescence microscopy, using propidium iodide (10 μg/ml,
Sigma) and Hoechst 33342 (10 μg/ml, Sigma), as previously
described for beta cells [1]. In p-NLS-EGFP-transfected cells,
nuclear morphology was directly examined under the fluores-
cence microscope (see Fig. S4). Apoptotic cells (<2n DNA;
sub-G1 cells) were also identified and counted by FACS, as
described [33]. Activity of caspase-3 enzyme in MIN6 cells was
determined using the fluorigenic substrate AC-DEVD-AMC
[4]. Caspase-3 activity was expressed as the number of arbitrary
fluorescence units (AMC fluorescence; 505 nm) measured per
milligram protein and per hour.
mRNA extraction and RT-PCR
Polyadenylated RNAwas extracted from MIN6 cells or from
rat primary beta cells using poly(dT)-coated magnetic microbe-
ads (Dynabeads, Dynal A.S, Oslo, Norway). Reverse transcrip-
tion and PCR amplification were carried out using the
GeneAmp RNA PCR kit (Perkin-Elmer Applied Biosystems).
Negative RT-PCR controls consisted of reactions without
reverse transcriptase. The oligonucleotide primers (Invitrogen)
used in this study, are listed in Table 1. Each PCR involved a
2Qmin initial denaturation step at 94°C, followed by 26–32
cycles with stages at 94°C for 30 s, at 55–65 °C for 30 s, and at
72°C for 1 min. PCR products were visualized on 1.2% agarose
gels stained with ethidium bromide, and the signals recorded
and quantified as previously described [27].
Western blot analysis
Cellular protein was extracted by a 1-min sonication in RIPA
buffer [34]. Protein concentration was determined by the micro-
BCA assay (Pierce, Rockford, IL) using bovine serum albumin
as the standard. Samples (25 μg protein) were mixed with SDS
loading buffer and boiled, separated on 12 or 15% SDS-
polyacrylamide gels and proteins were transferred to a
nitrocellulose membrane (Schleicher and Schuell Bioscience,
Dassel, Germany).
Specific antibodies recognizing the following proteins or
epitopes were used: casp-3 (gift from Dr. P. Vandenabeele),
human-Bcl-2 (ΔC 21), mouse-Bcl-2 (N-19) (Santa Cruz
Biotechnology, Santa Cruz, CA), phospho-(Thr 183/Tyr 185)-c-
jun-N-terminal kinase (JNK), total JNK (New England Biolabs,
Beverly, MA), phospho-(Thr 172)-AMPK (Cell Signaling
Table 1
Properties of primers used for RT-PCR on mRNA of MIN6 cells (M) or rat beta cells (R)
Gene Sense, antisense Primer sequence Annealing temperature (°C) Product size (bp)
A1/Bfl-1 (M) S 5′-AAAGAGTTGCTTTCTCCG-3′ 55 314
A 5′-ATCTTCCCAACCTCCATT-3′
A1/Bfl-1 (R) S 5′-AATCGGCTCCAAGCAAAA-3′ 60 290
A 5′-CGCCACAAAACTGGAAA-3′
Bad (M/R) S 5′-ATGTTCCAGATCCCAGAGTT-3′ 55 452 (M)
A 5′-CGATCCCACCAGGACTGGA-3′ 455 (R)
Bak (M/R) S 5′- ATGGCATCTGGACAAGGA-3′ 55 340 (M)
A 5′-TGGAGGCGATCTTGGTGAA-3′ 343 (R)
Bax (M/R) S 5′-GAACCATCATGGGCTGGACA-3′ 55 179
A 5′-TCAGCCCATCTTCTTCCAGA-3′
Bcl-2 (M/R) S 5′-AAAAAGAGGGGGGGCAAA-3′ 60 441 (M)
A 5′-AATCCGTAGGAATCCCAA-3′ 462 (R)
Bcl-xl (M/R) S 5′-GCCCATCTCTATTATAAAAAT-3′ 55 472 (M)
A 5′-CACAGTGCCCCGCCAAAGGAG-3′ 471 (R)
Bid (M/R) S 5′-AAGACGAGCTGCAGACA-3′ 55 314
A 5′- TTTGGCCAACAGCATTGT-3′
Bim (M/R) S 5′-GGTAATCCCGACGGCGAAGGGAC-3′ 55 160
A 5′-AAGAGAAATACCCACTGGAGGACC-3′
DP-5/Hrk (M/R) S 5′-GGACCGAGCAACAGGTT-3′ 55 267 (M)
A 5′-TGTGGAAAGGAAAGGGA-3′ 271 (R)
DP-5/Hrk (R) S 5′-AGCAACAGGTTGGCGAAA-3′ 55 175
A 5′-TAAATAGCACTGAGGTGG-3′
Mcl-1 (M/R) S 5′- GGCATGCTCCGGAAACT-3′ 55 263
A 5′-TCCACAAACCCATCCCA-3′
Noxa (M) S 5′-TGAGATGCCCGGGAGAAA-3′ 55 182
A 5′-TCATCCTGCTCTTTTGCGA-3′
Catalase (M/R) S 5-TCTGCAGATACCTGTGAACTG-3′ 60 357
A 5′-TAGTCAGGGTGGACGTCAGTG-3′
Glutathione peroxidase (M) S 5′-CTCGGTTTCCCGTGCAATCAG-3′ 65 431
A 5′-GTGCAGCCAGTAATCACCAAG-3′
Heat shock protein 70 (M) S 5-ACGCAGACCTTCACCACC-3′ 60 278
A 5′-CGCTCGATCTCCTCCTTG-3′
Beta actin (M/R) S 5′-CGTGGGCCGCCCTAGGCACCA-3′ 55 242
A 5′-TGGCCTTAGGGTTCAGAGGGG-3′
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Victoria, BC, Can), heat shock protein 70 (HSP70, Stressgen),
and β-actin (Santa Cruz Biotechnology). The appropriate
secondary antibodies conjugated with horseradish peroxidase
were applied, and immunoreactivities revealed by enhanced
chemiluminescence (Amersham Bioscience, Bucks, UK).
Statistical analysis of data
Quantitative data are presented as the mean ± SE of at least
three independent experiments. Statistical analysis of data was
done by Student's t test, or by one-way ANOVA using Dunnett's
test in multiple comparisons of means. Differences were
considered statistically significant if the p value was <0.05.
Results
Low glucose or AICAR cause mitochondrial dysfunction and
increased formation of oxygen radicals
We analyzed production of oxygen radicals in living
(propidium iodide negative) MIN6 cells cultured in either a
low glucose concentration or in the presence of the AMPK
activator AICAR.As a first approach, we measured ROS by following the
cellular oxidation of dihydrodichlorofluorescein diacetate, a
probe which is oxidized to green fluorescent DCF by various
peroxide-like ROS and nitric-oxide-derived reactive intermedi-
ates [35]. In H2-DCFDA-loaded MIN6 cells, the mean DCF
fluorescence was increased 1.7-fold by culture for 24 h in
0.6 mM glucose, as compared to MIN6 cells cultured under the
25 mM glucose control condition (P < 0.02 vs control; Fig. 1A).
A 1.7-fold increase of the mean DCF fluorescence was also seen
in cells cultured for 24 h in the presence of AICAR (p < 0.05 vs
control; Fig. 1A). We next used the superoxide-selective [36,37]
probe dihydroethidine to examine the superoxide anion
production in individual MIN6 cells by FACS. This showed
that the increased H2-DCFDA oxidation was associated with a
markedly increased mitochondrial superoxide formation as
measured by DHE (Supplementary Fig. S1). These results
indicated a sustained increase of superoxide(-derived) ROS
production under both low glucose and AICAR conditions.
Accordingly, the mRNA expression of antioxidant enzymes
glutathione peroxidase and catalase was significantly increased
at 24 h of culture in low glucose or AICAR, while the mRNA
expression of heat shock protein Hsp-70 was unaltered (Fig.
1B). Cellular expression of heme oxygenase-1 (HO-1) protein,
an inducible enzyme capable of cytoprotection via radical
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conditions (Fig. 1C).
The MTT (tetrazolium) colorimetric assay was used to
measure mitochondrial activity (MTT-reducing potential) in
MIN6 cells [31,32]. This showed that mitochondrial functionwas significantly inhibited at ≥12 h of culture in low glucose or
in the presence of AICAR, as compared to culture in 25 mM
glucose (Fig. 1D).
Chronic exposure (24 h) to AICAR in either 25 mM or low
glucose did not affect NAD(P)H in MIN6 cells (Fig. 1E). In
Fig. 2. Effect of low glucose or AICAR treatment on glucose-stimulated insulin secretion (GSIS), insulin content, glucose oxidation, and free fatty acid oxidation. (A)
MIN6 cells were cultured for 24 h, in 25 mM glucose (CTRL) or 0.6 mM glucose (LG), with or without AICAR (2 mM). Insulin secretion was then measured during
incubation of cells for 2 h in KRHBmedium supplemented with the indicated glucose concentrations. Released insulin was quantified (n = 4) by radioimmunoassay, as
described under Materials and methods. (B) Cells were then collected and their insulin content was analyzed. AICAR lowered the insulin content in both 25 and
0.6 mM glucose; *p < 0.05 vs no AICAR (−), n = 4. (C, D) MIN6 cells were cultured for 24 h as in A and their rates of glucose oxidation (C) and palmitate oxidation
(D) were measured as described under Materials and methods. *p < 0.05 vs CTRL, n = 3−5.
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the riboflavin oxidation status: 24-h exposure resulted in a
marked increase in oxidized FAD/FMN in abundant (25 mM)
glucose (Fig. 1E), probably reflecting decreased levels of
reduced FADH2/FMNH2. This also occurred in glucose-
deprived cells (Fig. 1E). Cellular NAD(P)H and FAD/FMN
were unaffected by 6-h exposure to AICAR, low glucose, or a
combination of both (Fig. 1E). Increased superoxide production
and inhibition of mitochondrial activity also required >6 h (Fig.
1D, and not shown). Thus, conditions that activate AMPK
increase the oxidized state of mitochondrial flavins, but do not
affect NAD(P)H formation. This redox imbalance correlatesFig. 1. Stimulation of peroxide-like ROS production in MIN6 cells. (A) MIN6 cell
without (CTRL) or with 2 mM AICAR, and peroxide-like ROS was detected with H
6) for DCF oxidation in cells are normalized by expressing the mean fluorescence i
population (CTRL). (B) mRNA expression of glutathione peroxidase (GPX), cata
primers see Table 1). Actin was used as internal control (not shown). Data in the righ
(*p < 0.05 vs CTRL). (C) Western blotting for heme oxygenase-1 (HO-1), HSP-70
right panel (mean ± SE, n=3) are expressed as fold protein under control cond
mitochondrial activity by glucose limitation (square symbols) or addition of 2 mM A
assay. MTTwas added to cell culture wells 2 h prior to the endpoint, and the formaza
mean ± SE of 4–7 experiments (*p < 0.05, **p < 0.01, ***p < 0.001). (E) MIN6 ce
(200 nM, 5 min). Using FACS, NAD(P)H fluorescence (left) and riboflavin (FAD-FM
MIN6 cells, as described under Materials and methods. As positive control for the N
included. Data represent average mean fluorescence index (MFI) ± SE normalized twith increased superoxide formation and mitochondrial dys-
function in beta cells.
Low glucose or AICAR inhibit glucose-stimulated insulin
secretion (GSIS) and cellular oxidation of glucose but not of
palmitate
We next examined whether these mitochondrial effects
functionally disabled the MIN6 cells. Exposure of MIN6 cells
to low glucose (0.6 mM) for 24 h markedly reduced their GSIS
(Fig. 2A). Exposure to AICAR (2 mM) in either normal glucose
(25 mM) or low glucose (0.6 mM) resulted in nearly completes were cultured for 24 h in 0.6 mM glucose (LG), or in 25 mM glucose either
2DCFDA by flow cytometry (see Materials and methods). Data (mean ± SE, n =
ndex (MFI) for the respective cell population relative to the MFI of the control
lase, and heat shock protein 70 (HSP70) was analyzed by RT-PCR (for PCR
t panel (mean ± SE, n = 4) are expressed as fold mRNA under control conditions
, and actin was performed using specific antibodies (see Methods). Data in the
itions (*p < 0.05 vs CTRL). (D) Time-dependent inhibition of MIN6 cell
ICAR (circles). Mitochondrial activity was measured using the MTT-reduction
n produced was measured spectrophotometrically at 490 nm. Data represent the
lls were cultured for 24 h as described in A, or in the presence of antimycin A
N) fluorescence (right) were subsequently measured in populations of dispersed
AD(P)H measurement a 5-min exposure to complex III inhibitor antimycin was
o MFI in control (25 mM glucose). *p < 0.05 vs CTRL, n = 4.
Fig. 4. ROS species are early mediators of the apoptosis. MIN6 cells were
cultured for 24 h under control conditions (CTRL) or in low glucose (LG) as
well as in LG supplemented with chemical ROS scavengers vitamin E (vitE),
N-acetylcysteine (NAC), pyruvate, and the SOD-mimetic compound MnTBAP,
as indicated. (A) ROS was measured by FACS analysis and the data (n = 8–10,
mean ± SE, *p < 0.02, § p < 0.01 vs LG) were expressed as in Fig. 1. (B) DNA
degradation was measured by FACS using the fluorescent probe propidium
iodide. Data (n = 6–12; § p < 0.01 vs LG) are expressed as the percentage of
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culture in low glucose did not result in an increased cellular
insulin content, as compared to culture in 25 mM glucose (Fig.
2B). The insulin content ofMIN6 cells cultured in the presence of
AICAR was decreased by ±30% (Fig. 2B). These data confirm
earlier published results showing that AMPK activation inhibits
insulin biosynthesis [5] and release [6]. They also suggest that
AMPK inhibition of GSIS is not primarily mediated by changes
in the cellular insulin stores. Since GSIS is dependent on
mitochondrial oxidative activity, we next examined whether
AMPK activation affected the glucose-oxidation rate of MIN6
cells. The data in Fig. 2C show that preexposure of the cells to
low glucose, AICAR, or a combination of both decreased their
glucose-oxidation rate by 50–70%. Under the same conditions,
the rate of palmitate oxidation was unaltered (Fig. 2D). The
results indicate that AMPK activation decreases the oxidation of
glucose-carbon in the mitochondria, apparently without com-
pensatory increase in the oxidation of free fatty acids. This is
consistent with the observed reduction in mitochondrial activity
(MTT assay) and with the suppression of GSIS.
Low glucose- or AICAR-induced ROS formation results in
apoptosis
As we previously reported [4], MIN6 cells exposed to either
a low glucose concentration (0.6 mM) or to AICAR (2 mM)
underwent apoptosis (Fig. 3A). This effect was seen at 24 h and
was more pronounced at 48 h (Fig. 3A), while necrosis affected
less than 1% of the cells under these conditions (Fig. 3B). To
examine whether the increased ROS formation participated in
apoptosis onset, MIN6 cells were exposed to low glucose for
24 h in the absence or presence of ROS scavengers, and
apoptosis rates were determined by FACS. The compounds
vitamin E (5 μM), N-acetylcysteine (1 mM), and the superoxide
dismutase mimetic MnTBAP (10 μM) all scavenged ROS (Fig.
4A) and prevented apoptosis (Fig. 4B) induced by low glucose.
In addition, the metabolic fuel pyruvate (5-10 mM) could
substitute for glucose in that it also suppressed both ROS
production and apoptosis in MIN6 cells (Figs. 4A and B). WithFig. 3. Low glucose concentrations or AICAR induce apoptosis in MIN6 cells.
Cells seeded in 96-well plates were exposed to medium containing either 25 mM
glucose (CTRL), 0.6 mM glucose (LG), or 2 mM AICAR, for 24 or 48 h. The
percentages of (A) apoptotic and (B) necrotic cells were determined by direct
counting under the fluorescence microscope after propidium iodide and Hoechst
staining. Data represent the mean ± SE of 5 independent experiments. *p<0.01
vs CTRL.
cells with <2n DNA (% sub-G1 cells). (C) ROS production was not inhibited in
NeoR B1 cells expressing hBcl-2 (n = 5; *p < 0.01 vs CTRL).the exception of vitamin E, the scavengers used here to sup-
press apoptosis also inhibited the accumulation of superoxide
(Supplementary Fig. S1).
Increased expression of BH3-only proteins may activate and
ectopic expression of hBcl2 inhibits an intrinsic apoptosis
pathway under conditions of AMPK activation
Low glucose or AICAR induce apoptosis only when applied
for≥ 24 h in MIN6 cells and beta cells (Fig. 3A, and [3,4]). It is
unknown whether alteration in gene expression by AMPK
activation can contribute to mitochondrial dysfunction and cell
death. BH3-domain-only proteins are transcriptionally regu-
lated inhibitors of the antiapoptotic function of Bcl-2 in several









































































































Fig. 5. RT-PCR analysis of Bcl-2-family genes. (A) MIN6 cells and (B)
primary beta cells were cultured in medium containing low glucose or
AICAR for 24 h. mRNA was isolated and subjected to semiquantitative RT-
PCR using specific primers (see Table 1). Data are expressed as fold mRNA
in control cells, and represent the mean ± SE of 4–5 experiments in A and 5–
8 experiments in B. *p < 0.05 vs control.
Fig. 6. High level expression of human Bcl-2 prevents low glucose and AICAR-
induced apoptosis. Stable transfectants (NeoR) expressing human Bcl-2 (hBcl-2)
were obtained as described in the text. (A) Human Bcl-2 protein expression was
detected with antibody specific for human Bcl-2 in NeoR-resistant MIN6 cells
that had been transfected with empty vector pEF1 (left panel, clones P1-P4) or
with pEF1-hBcl2 (right panel, clones B1–3 and B5–9), or in nontransfected
MIN6 cells (−). Clones B2 and B5 expressed detectable but low levels of hBcl-2
protein. (B) Apoptosis induction was assessed by cell counting under the
fluorescence microscope (as in Fig. 3) in stable NeoR clones that showed low or
no hBcl-2 expression (left), and in clones that expressed high levels of hBcl-2
(right), after culture under control conditions, 0.6 mM glucose, or 2 mM
AICAR, for 48 h. Data represent the mean ± SE of 4–6 independent
experiments. Low glucose and AICAR both induced significant effects in clones
P1, P4, B2, and B5 (p < 0.01 vs CTRL).
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or AICAR. In MIN6 cells, the proapoptotic BH-3-only
members DP-5/Hrk and Bid were up-regulated, and antiapop-
totic A1-mRNA was decreased under both conditions. Proa-
poptotic BH-3-only Noxa mRNAwas also increased in AICAR
(Fig. 5A). In primary beta cells, DP-5/Hrk was again up-
regulated by both low glucose and AICAR, while the BH3-only
family member Bim, and death agonist Bak, were also increased
in AICAR (Fig. 5B). Antiapoptotic homologues Bcl-2, Bcl-xL,
and Mcl-1 were not significantly altered in MIN6 cells (Fig. 5A)
or in beta cells (Fig. 5B). Thus, under conditions of AMPK
activation and concomitant with cell death induction, the
expression of proapoptotic BH3-only mRNA is up-regulated
consistently for DP5/Hrk. Depending on the cell type, AICAR
additionally induces Bid, Bim, or Noxa. Together, the results
suggest a role for BH3-only members of the Bcl-2 family in
AICAR and low glucose-induced apoptosis.To investigate the involvement of mitochondrial mediators in
the onset of apoptosis in these models, MIN6 cells that stably
expressed the human Bcl-2 protein (hBcl-2) were generated.
MIN6 cells were transfected with empty vector (pEF1) or with
plasmid pEF1-hBcl-2 and maintained in G418 (400 μg/ml).
Neomycin/geneticin-resistant (NeoR), clonally expanded cells
were thus obtained that either stably expressed h-Bcl2 (B1, 3, 6,
7, and 9; Fig. 6A) or were negative for the protein (P1-4; Fig.
6A). These cells were then exposed for 48 h to a low glucose
concentration (0.6 mM) or to AICAR (2 mM) and apoptotic
cells were counted using fluorescence microscopy (Fig. 6B) and
by FACS measurement of cellular DNA degradation (Supple-
mentary Fig. S2). This showed that both low glucose and
AICAR induced apoptosis in NeoR cells that did not express
hBcl-2 (P1, 4; Fig. 6B), whereas apoptosis was inhibited in
MIN6 cells expressing hBcl-2 (B1, 3, 6, 7; Fig. 6B). Cell death
inhibition in hBcl-2-expressing cells was also evident in light
microscopy (Supplementary Fig. S3). Thus, Bcl-2 potently
counteracts apoptosis induction by low glucose or AICAR,
suggesting that crucial cell death mediators derive from, or
target, the beta cell mitochondria.
Fig. 7. Low glucose concentrations or AICAR induce casp-3 activation and Bcl-
2-cleavage in beta cells. (A) Western blot showing the time course of proteolytic
casp-3 activation and Bcl-2 cleavage in MIN6 cells exposed to 0.6 mM glucose.
Pro (32 kDa) and activated (17 kDa) forms of casp-3 were detected using casp-3-
specific antibody. The 26-kDa Bcl-2 protein as well as a 24-kDa Bcl-2 protein
were detected at time points ≥24 h, using a Bcl-2-specific antibody. (B) MIN6
cells were cultured in 25 mM glucose (+) or in 0.6 mM glucose (−) for 24 h in
the absence or presence of 50 μM of the general caspase inhibitor z-VAD-fmk,
and the appearance of truncated Bcl-2 (24 kDa) was evaluated by Western
blotting. Two experiments are shown (lanes 1–3 and 4–6). (C) Increased
cleavage of Bcl-2 protein was detected in lysates of 2×105 rat beta cells that
were cultured for 72 h in 3 mM glucose (lane 2) or 2 mM AICAR (lane 4), as
compared to culture in 10 mM glucose (lane 1). z-VAD-fmk partially inhibited
the Bcl-2 cleavage caused by the low glucose concentration (lane 3). Results
shown are representative of 3–4 experiments.
Fig. 8. Transient expression of Bcl-2 or p35 reduces apoptosis. MIN6 cells were
transfected with 0.5 μg of plasmid pNLS-EGFP encoding nuclearly targeted
GFP, together with 0.5 μg of empty control vector (pEF1) or a plasmid
expressing the baculovirus p35 (pCAGGS-p35), cowpox virus crmA (pEF1-
crmA), or human Bcl-2 gene (pEF1-hBcl2). Cells were then cultured in medium
containing 0.6 mM glucose for 48 h. Percentage apoptosis was scored in GFP-
expressing cells by examining their nuclear morphology under the fluorescence
microscope (see Fig. S1). Data represent the mean ± SE of 6 independent
experiments. *p < 0.001 vs pEF1.
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apoptosis
In MIN6 cells, low glucose concentrations or AICAR
induced a time-dependent proteolytic activation of caspase-3,
paralleled by conversion of the 26-kDa Bcl-2 protein to a Bcl-2
protein of 24 kDa (Fig. 7A, and not shown). Low glucose-
induced cleavage of the Bcl-2 protein was suppressed by
addition of 50 μM of the broad-spectrum caspase-inhibitor z-
VAD-fmk (Fig. 7B, lanes 2–3 and 5–6). In primary beta cells,
Bcl-2 protein cleavage was induced by culture in 3 mM glucose
(Fig. 7C, lanes 1–2) or in medium containing 10 mM glucose
and 1 mM AICAR (Fig. 7C, lane 4), and was inhibited byzVAD-fmk (Fig. 7C, lanes 2–3). These data indicated that both
AICAR and low glucose induced a caspase-dependent trunca-
tion of Bcl-2 in beta cells.
To evaluate whether specific caspase subtypes contribute to
beta cell death, MIN6 cells were transiently transfected with
plasmids encoding either baculovirus p35 protein (pCAGGS-
p35) or cowpox CrmA protein (pEF1-crmA), known inhibitors
of casp-3- and casp-1-like enzymes, respectively. Cotransfection
with plasmid pNLS-GFP, which drives a nuclearly targeted GFP
expression, allowed for direct microscopic counting of the
percentage of transfected cells undergoing nuclear apoptosis
(supplementary Fig. S4). In low glucose, apoptosis was
decreased in MIN6 cells transfected with pCAGGS-p35, as
compared to cells transfectedwith empty pEF1-vector or plasmid
pEF1-crmA (Fig. 8). Similar results were obtained in the
presence of AICAR (supplementary Fig. S4). Under these
conditions, apoptosis was also inhibited by transfection with
plasmid pEF1-hBcl-2 expressing recombinant humanBcl-2 (Fig.
8). The results suggest that activation of casp-3 but not of casp-1,
and possibly the ensuing caspase-dependent truncation of Bcl-2,
contributes to low glucose and AICAR-induced apoptosis.
Bcl-2 does not reduce ROS formation, or AMPK and JNK
activation, but protects against caspase-3 activation and
apoptosis
In response to long-term culture in low glucose or AICAR,
the ROS production in MIN6 cells that stably expressed h-Bcl-2
protein was similar to that in control MIN6 cells (Fig. 4C).
Thus, elevated ROS production contributes to apoptosis but is
not influenced by increased Bcl-2 expression, indicating that
ROS species are early mediators of apoptosis.
Although casp-3 is widely considered an executioner
caspase, casp-3 activation coupled to Bcl-2 cleavage has been
reported to initiate apoptosis in some systems [40]. We tested
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glucose or AICAR. Culture under either condition increased
caspase-3 activity in NeoR control MIN6 cells, whereas thisFig. 9. hBcl-2 expression prevents proteolytic activation of caspase-3 and
cleavage of endogenous Bcl-2 in MIN6 cells, but does not influence AMPK and
JNK phosphorylation. (A) The NeoR cells were treated as in Fig. 6, and specific
activity (U/mg h) of casp-3 was measured fluorometrically (see Materials and
methods). Data represent mean ± SE of 4 independent experiments. (B) Cells (as
in A) were analyzed by Western blotting for conversion of pro-casp-3 (32 kDa)
to active casp-3 (17 kDa), and for truncation of endogenous (mouse) Bcl-2.
(C=CTRL, L=low glucose, A=AICAR). B3 and B7 cells, with high level
h-Bcl-2 expression, showed no casp-3 processing, nor truncation of endogenous
Bcl-2. Anti-mouse Bcl-2 antibody cross-reacted with high levels of the human
Bcl-2 protein in B3 and B7. (C) Phosphorylation of AMPK (p-AMPK) and JNK
(p-JNK1 and 2) was studied by Western blotting in B1- and B7 cells with high
level h-Bcl-2 expression and in P1 cells negative for hBcl-2. Phosphorylation
was induced by 4-h culture in 2 mM AICAR. Blots shown are respresentative of
3 experiments.response was suppressed in NeoR MIN6 cells exhibiting hBcl-2
expression (Fig. 9A). Immunoblotting showed a clear proces-
sing of pro-casp-3 (32 kDa) in NeoR control cells in response to
the apoptotic conditions, whereas casp-3 was not processed in
NeoR cells that expressed hBcl-2 (Fig. 9B). In the latter,
endogenous (mouse) Bcl-2 protein was also no longer truncated
to 24 kDa (Fig. 9B). AMPK and JNK activation are early
signals that contribute to the apoptosis pathway [3–5,8]. In
keeping with this, hBcl-2 expression did not prevent activation
of these kinases in MIN6 cells exposed to AICAR (Fig. 9C).
The results indicate that casp-3-activation and truncation of
endogenous Bcl-2 occur downstream of the point of action of
hBcl-2 in the apoptosis pathway. Together our data suggest that
early mitochondrial dysfunction and ROS formation contribute
to apoptosis initiation while casp-3 and Bcl-2 processing may
amplify the mitochondrial death signal.
Discussion
Recently, we demonstrated that acute reduction of glucose
metabolism stimulates the mitochondrial ROS production in
purified rat beta cells. This effect was explained by decreased
mitochondrial metabolic rate, and an associated oxidized state
of flavin (FAD/FMN) cofactors in the electron transport chain
resulting in superoxide formation [24]. In the present study we
examined the mechanistic contribution of ROS to cell death
induced by sustained AMPK activation in MIN6 cells (1)
cultured in a low glucose concentration or (2) in the presence of
AICAR.
ROS generation was measured with two probes, namely the
sensitive but unspecific H2-DCF that is oxidized by various
peroxide-like ROS but also by nitric oxide-derived reactive
species [35], and the superoxide-selective probe, DHE [36]. The
oxidation of both probes was increased following a sustained
exposure to low glucose or AICAR. The observation that ROS
scavengers that reduced the DHE oxidation (superoxide)
proportionately reduced H2-DCF oxidation shows that both
probes detect radicals derived from a single source. The most
plausible scheme is that this source is superoxide, primarily
generated at the electron transport chain. Subsequent formation
of complex peroxide species, dismutation of superoxide to
H2O2-compatible with the concomitant increase in catalase
expression-and/or formation of peroxynitrite then result in H2-
DCF oxidation. Additional proof for this sequence of events
comes from the fact that the strictly mitochondrial fuel pyruvate,
which is taken up and metabolized by MIN6 cells [28], also
prevented the accumulation of both superoxide and the DCF
signals in low glucose-exposed cells. Glucose deprivation-
induced ROS formation has previously been observed in breast
cancer cell lines [41,42] and in HepG2 hepatoma cells [43]. The
latter study also showed that ROS formation under conditions of
glucose deprivation required a functional electron transport
chain and that the mechanism can be considered as a novel
mechanism of metabolic signaling, leading to the induction of
various genes such as heme oxygenase-1. A novel finding in our
study is that the AMPK activator AICAR also induced formation
of superoxide (-derived ROS). That this was associated with
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(oxidized redox state of FAD/FMN cofactors) suggests a causal
relationship. It is conceivable that semioxidized flavins are more
prone to superoxide formation [44], which is also compatible
with the earlier observed association of oxidized flavins with
mitochondrial ROS in primary beta cells [24]. The increased
ROS production under these conditions is indicative of a
mitochondrial dysfunction. Our MTT assay data show that both
low glucose and AICAR rapidly decrease the mitochondrial
metabolic activity. Since several radical scavengers suppress the
ROS accumulation inMIN6 cells and also significantly decrease
cell death, we conclude that increased mitochondrial ROS
generation is not an epiphenomenon of the cell death observed
under the given culture conditions but is a mechanism which
contributes to the apoptosis.
Our observations in MIN6 cells that-with a similar time
course-both low glucose concentration and AICAR (1)
enhanced superoxide production, (2) decreased mitochondrial
activity (MTT assay), and (3) increased oxidation state of FAD/
FMN suggest that AMPK activation can result in mitochondrial
dysfunction. This is consistent with the results showing that
both AICAR and low glucose markedly decreased glucose-
oxidation and suppressed the glucose-induced insulin secretion
in MIN6 cells. In view of the finding that the insulin stores were
not increased in low glucose and were reduced in AICAR, the
data are consistent with our earlier results showing that the
AMPK activators metformin and AICAR decrease beta cell
biosynthetic activity [5]. In addition, our data corroborate the
observations made by others that expression of CA-AMPK
results in decreased glucose oxidation, cellular [ATP], and
insulin secretion, in mouse and rat pancreatic islets or MIN6
cells [6,7]. We conclude from these results that the suppression
of glucose oxidation and beta cell function reflect an inhibitory
action of AMPK on mitochondrial function. This inhibitory
action, however, selectively affects the glucose branch of
mitochondrial metabolism: even after a sustained period of
exposure to low glucose and/or AICAR which resulted in
suppressed glucose oxidation, protein biosynthesis inhibition,
and ROS formation, palmitate oxidation was unaffected.
The notion that increased superoxide production can result
from a decreased glucose metabolism is not new in beta cells
[24], and was previously demonstrated in various other cell
types [41–43]. Moreover, it was recently shown that increased
ROS production by chronic hyperglycemia in beta cells was
associated with-paradoxically-lowered glucose metabolism and
decreased association of glucokinase with mitochondria [45]. It
would be interesting to investigate whether AMPK activation
by AICAR downregulates (mitochondrially associated) gluco-
kinase: such action (1) would affect glucose metabolism
similarly as when cells are exposed to a low glucose
concentration, (2) could explain its specific inhibitory effect
on glucose oxidation, (3) could help to clarify the mitochondrial
ROS generation. Indeed, GK downregulation would not only
decrease the formation of antioxidative NAD(P)H equivalents
from glucose [46], but also preclude recycling of ADP at the
mitochondria, resulting in state IV respiration, mitochondrial
membrane hyperpolarization, and superoxide production[47,48]. An additional question which we have not adressed
and which warrants further study in the present context is
whether AMPK activation influences glucose utilization in beta
cells.
It is at present unclear how AMPK activation causes redox
imbalance with increased oxidized state of mitochondrial
FADH2/FMNH2 but not total cellular NAD(P)H. Possibly, an
AMPK-activated Randle effect is involved here: AMPK has
been shown to be a strong activator of fatty acid beta-oxidation,
in part chronically via PPAR alpha/PGC-1-mediated phenotypic
adaptations [49]. Increased oxidation of fatty acids-which are
present in serum-containing medium-will increase the mito-
chondrial acetyl-coA/coA ratio, and hence slow down the flux
of glucose-derived pyruvate through the pyruvate dehydrogen-
ase complex (PDH) [50,51]. Such a metabolic scenario has been
shown to evolve gradually with time in beta cells after
prolonged fasting, and has been implied in the decreased
glucose oxidation in beta cells under this condition [51].
Glucose carbon will then be shunted away from oxidation, via
pyruvate carboxylase, to malate which then participates in NAD
(P)H)-generating reactions in the cytoplasm [50]. Palmitate
oxidation in MIN6/beta cells, in terms of carbon equivalents
oxidized, is low as compared to glucose oxidation (our data,
Fig. 2), and is thus expected to generate limited amounts of
mitochondrial NADH/FADH2 and ATP, which entails a shut-
down of GSIS via inactivation of the triggering, K+ATP-
dependent pathway of GSIS [52]. If this occurs in MIN6 cells
chronically exposed to AICAR, and/or glucose deprivation, the
oxidized mitochondrial flavins would represent a combination
of oxidized soluble Krebs cycle FAD, FMN in electron transport
chain I, and FAD in the PDH complex. While flavins are mainly
mitochondrial, our NAD(P)H measurements reflect both
cytoplasmic and mitochondrial levels. In normal, glucose-
stimulated beta cells there is a close equilibration between
mitochondrial NADH and FADH2 [53]. Together, this leaves
the possibility that in AICAR-exposed MIN6 cells the
decreased glucose oxidation is in fact accompanied, not only
by decreased mitochondrial FADH2/FMNH2 but also by
decreased NADH, the latter masked by increased cytoplasmic
NAD(P)H. Such a scenario can also explain the markedly
decreased mitochondrial redox potential, measured by MTT
assay. An oxidized state of mitochondrial NADH and FAD/
FMN in beta cells was previously associated with increased
oxygen radical formation from an oxidized FMN or associated
Fe-S cluster in complex I [24]. Ultimately, the combination of
ATP depletion, inhibited protein synthesis and mitochondrial
ROS formation creates a vicious cycle, secondarily slowing
down beta oxidation despite its intrinsic stimulation by AMPK.
This model (see Fig. 10) predicts that pharmacological
inhibition of beta-oxidation in AICAR-exposed MIN6 might
partially correct the observed AICAR suppression of glucose
oxidation, as was previously shown for fasting-induced
suppression of glucose oxidation in beta cells [51].
It was previously shown that JNK is a mediator of apoptosis
induction by AICAR or CA-AMPK in MIN6 cells [4]. Both
JNK and its downstream target, c-Jun, are also activated in
MIN6 cells cultured in low glucose concentrations [4]. In
Fig. 10. Hypothetical mechanism of AICAR-induced inhibition of mitochondrial metabolism and FADH2/NAD(P)H imbalance. AMPK activation stimulates fatty acid
oxidation which leads to inhibition of pyruvate dehydrogenase (PDH) and glucose oxidation (Randle effect). This decreases mitochondrial NADH and FADH2,
favoring an oxidized state of the respiratory chain. This in turn leads to ROS formation through keeping FMN unsaturated in complex I, as previously proposed [24].
The pyruvate/malate shuttle generates cytosolic NADPH, leaving a relative deficiency of mitochondrial FADH2 vs total NAD(P)H. Under sustained AMPK activation,
however, ATP depletion, inhibition of protein synthesis, and mitochondrial oxygen radical formation then create a vicious cycle, causing general mitochondrial
metabolic dysfunction, ultimately also affecting fatty acid oxidation.
75Y. Cai et al. / Free Radical Biology & Medicine 42 (2007) 64–78hemapoietic progenitor cells and neurons, JNK and c-Jun have
been implicated in initiation of apoptosis through transcriptional
regulation of BH3-only genes, including DP-5 and Bim [54–
56]. Proapoptotic BH3-only members of the Bcl-2 family can
cooperate with BH3 containing proteins Bax and Bak to induce
release of mitochondrial proteins such as cytochrome c [39].
While BH3-only members are subject to stringent control in
normal cells, BH3-only subsets that are regulated at the RNA
level can be promptly upregulated in response to apoptotic
signals. A few genes, such as hrk/dp5 [57,58], noxa [59],
puma/bbc3 [60,61], bim [62,63], and bid [64] are activated by
transcription. However, activation of each of these genes was
reported in non-beta-cell types ranging from primary cells
(neurons, lymphocytes, thymocytes, colon) to tumor cells [57–
64], and beta cells or MIN6 cells might respond differently. The
present study examined the modulation of BH3-only proteins at
the RNA level in beta cells and MIN6 cells. Our RT-PCR study
showed that at 24 h, BH3-only mRNA encoding DP5 or Bim
were upregulated, while antiapoptotic paralogs were either
unaffected or downregulated under conditions of AMPK
activation. The data suggest that increased expression of certain
BH3-only members of the Bcl-2 family can contribute to
apoptosis onset under conditions of AMPK activation. The
observed upregulation of DP5 and Bim may constitute a
functional link between JNK activation and cell execution in
our models, although this requires further investigation.
The dysregulation of BH3 members of the Bcl-2 family
observed in the present study suggests that activation of theintrinsic apoptosis pathwaymediates beta cell death. This notion
is supported by preventing apoptosis in MIN6 cells through
stable expression of recombinant human Bcl-2 protein. The
present analysis confirms the results of previous studies
implicating the mitochondrial pathway in AICAR-induced
apoptosis [11,65], and extends the finding to other conditions
associated with sustained AMPK activation. AICAR triggers
apoptosis independently of AMPK activation and ZMP synth-
esis in Jurkat cells [65], whereas AMPK activation contributes to
AICAR-induced apoptosis in liver cells, beta cells, B-lympho-
cytes and gastric cancer cells [3,4,8,10,11]. Our study showing
that two AMPK-activating conditions lead to mitochondrial
dysfunction, together with the observations that pharmacologi-
cal AMPK activators and CA-AMPK can decrease glucose
oxidation in beta cells [5–7], strongly suggests that mitochon-
drial inhibition and ensuing ROS production are part of the
AMPK-mediated apoptosis pathway. Since AMPK activation by
low glucose or AICAR occurs rapidly [3,4], before ROS
production is significantly increased in MIN6 cells (not shown),
the ROS formation is not a likely stimulator of AMPK in our
models. A contributory role of ROS species on the long-term
activation of AMPK in beta cells can, however, not be excluded
[66]. Our data show that the increased ROS production is an
early event with respect to the apoptotic execution, since it was
unaffected by enhanced Bcl-2 expression.
In both low glucose and AICAR, caspase-3 was proteolyti-
cally activated, an event that was paralleled by caspase-
dependent truncation of the antiapoptotic regulator Bcl-2.
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other systems to yield a Bax-like death effector responsible for
triggering apoptosis [40]. Our study therefore suggests that Bcl-
2 truncation can contribute to apoptosis of beta cells under these
culture conditions. This is supported by the observation that
transient transfection of plasmids encoding either human Bcl-2
or baculovirus p35, a selective inhibitor of casp-3, both inhibited
MIN6 cell death. To examine whether the observed processing
of caspase-3 and Bcl-2 acts proximally or distally in the
apoptosis program, MIN6 cells were studied that stably express
the human Bcl-2 protein. When the cells were exposed to either
low glucose or AICAR for up to 48 h they remained viable and
did not exhibit casp-3 processing or activation, nor truncation of
recombinant or endogenous Bcl-2. This indicates that the
processing of casp-3 and Bcl-2 occurs distally with respect to the
antiapoptotic action of Bcl-2. In contrast, phosphorylation of
AMPK and JNK was not inhibited by ectopic Bcl-2 expression,
which is in agreement with the proximal role of these kinases in
the apoptosis pathway [4,8].
In conclusion, the present data suggest that AMPK activation
in beta cells leads to mitochondrial dysfunction and increased
ROS production, which contributes to activation of the intrinsic
mitochondrial apoptosis pathway. Processing of Bcl-2 partici-
pates in amplification rather than initiation of beta cell death.
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